Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4261067 | 0.81 | PTGS2 (0.44) | PTGS2CYP1A2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL5326026 | 0.81 | PTGS2 (0.67) | PTGS2TSHRKMT2APTGS1LMNA | |
| Hydrogen Peroxide SCHEMBL5496256 | 0.78 | ALDH1A1 (0.58) | CYP1A2CYP2D6MAPK1HSD17B10SMN1; SMN2 | |
| Hydrogen Peroxide SCHEMBL7816450 | 0.78 | ALDH1A1 (0.58) | CYP1A2CYP2D6MAPK1HSD17B10SMN1; SMN2 | |
| SCHEMBL9247846 | 0.78 | MMP8 (0.45) | PTGS2CYP1A2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL7732399 | 0.78 | PTGS2 (0.45) | PTGS2CYP1A2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL28912418 | 0.78 | CYP2C19 (0.56) | PTGS2CYP1A2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL271988 | 0.76 | SRC (0.78) | SRCPTGS2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL28309551 | 0.76 | CYP1A2 (0.45) | PTGS2CYP1A2CYP2D6MAPK1HSD17B10 | |
| SCHEMBL2209126 | 0.75 | SRC (0.56) | SRCPTGS2TSHRPPARGKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6759103-B2 | NEMATIC, CHOLESTERIC OR CHIRAL SMECTIC LIQUID-CRYSTAL MIXTURES HAVING HIGH ABSOLUTE DIELECTRIC ANISOTROPY VALUES AND WITH A FAVORABLE VISCOSITY/CLEARING POINT RELATIONSHIP; PHOTOSTABILITY; HEAT AND ULTRAVIOLET RADIATION RESISTANCE | CLARIANT FINANCI (BVI) LIMITED (VG) | 2004-07-06 | — | — | US | disclosed |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | CLARIANT INTERNATIONAL LTD. | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | SCO2, CNOT1, HCFC1 | SRC 2618/4885PTGS2 1920/4885CYP1A2 1720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.